Table 2.
Univariate and multivariate linear regression analyses for continuous flow-mediated dilation
| Univariate analysis | Multivariate analysis | |||
|---|---|---|---|---|
| Variable | Beta (SE) | p value | Beta (SE) | p value |
| Deep venous thrombosis | −4.10 (0.83) | <0.001 | −4.14 (0.80) | <0.001 |
| Age | −0.05 (0.03) | 0.089 | −0.01 (0.03) | 0.589 |
| Gender (male) | −1.66 (0.91) | 0.070 | −1.37 (0.77) | 0.079 |
| Obesity | −2.46 (0.94) | 0.010 | −2.04 (0.85) | 0.018 |
| Smoke | −0.06 (1.03) | 0.952 | −0.25 (0.86) | 0.774 |
| Dyslipidemia | −2.84 (0.96) | 0.004 | −0.34 (1.36) | 0.805 |
| Cardiovascular disease | −1.02 (1.95) | 0.602 | −2.43 (1.66) | 0.145 |
| Arterial hypertension | −1.89 (0.94) | 0.046 | −0.23 (1.02) | 0.818 |
| Diabetes mellitus | −1.25 (1.52) | 0.413 | 0.10 (1.35) | 0.943 |
| Platelet anti-aggregating drugs | −2.35 (0.98) | 0.018 | −1.66 (0.89) | 0.066 |
| Statins | −1.93 (1.05) | 0.069 | −1.30 (1.43) | 0.366 |